MSD-backed Ray locks in $125m to back eye drug pipeline [Yahoo! Finance]
Janus Henderson Group plc Ordinary Shares (JHG)
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am
Check Earnings Report
US:NYSE Investor Relations:
snl.com/irw/corporateprofile/4147331
Company Research
Source: Yahoo! Finance
Through the oversubscribed round, which was led by Janus Henderson Investors and featured contributions from MSD's (Merck & Co) venture arm, MRL Ventures Fund and Novo Holdings, Ray will fund the late-stage clinical development and commercial readiness of RTX-015. Ray is currently evaluating RTX-015 through the Phase I ENVISION study (NCT06460844), which is looking at the drug's potential in patients with retinitis pigmentosa (RP), a genetic disease which causes the light-sensitive cells in the retina to break down. RTX-015 acts by delivering a light-sensitive receptor protein called a rhodopsin to surviving retinal neurons, which then repurpose into light-sensitive photoreceptors – thus effectively replacing photoreceptors lost in the eye, regardless of genetic mutations. This differs from the approach harnessed by Spark Therapeutics' and Novartis' approved RP medicine, Luxturna (voretigene neparvovec), which delivers a copy of the RPE65 gene to restore the RPE65 enzyme's func
Show less
Read more
Impact Snapshot
Event Time:
JHG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JHG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JHG alerts
High impacting Janus Henderson Group plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JHG
News
- Janus Henderson continues to be overweight international markets [Seeking Alpha]Seeking Alpha
- We continue to be overweight international markets, says Janus Henderson's Michael Contopoulos [CNBC]CNBC
- Data center frenzy stoked by high-yield bond binge [Yahoo! Finance]Yahoo! Finance
- Janus Henderson Launches Two Structured Income ETFsBusiness Wire
- Janus Henderson shareholders approve Trian/General Catalyst deal [Seeking Alpha]Seeking Alpha
JHG
Earnings
- 1/30/26 - Beat
JHG
Sec Filings
- 4/17/26 - Form DEF
- 4/17/26 - Form DEFA14A
- 4/17/26 - Form ARS
- JHG's page on the SEC website